rs1131820

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002249.6(KCNN3):​c.1047T>C​(p.Asn349Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.738 in 1,613,634 control chromosomes in the GnomAD database, including 442,919 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 39672 hom., cov: 34)
Exomes 𝑓: 0.74 ( 403247 hom. )

Consequence

KCNN3
NM_002249.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.41

Publications

32 publications found
Variant links:
Genes affected
KCNN3 (HGNC:6292): (potassium calcium-activated channel subfamily N member 3) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. This gene belongs to the KCNN family of potassium channels. It encodes an integral membrane protein that forms a voltage-independent calcium-activated channel, which is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene contains two CAG repeat regions in the coding sequence. It was thought that expansion of one or both of these repeats could lead to an increased susceptibility to schizophrenia or bipolar disorder, but studies indicate that this is probably not the case. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
KCNN3 Gene-Disease associations (from GenCC):
  • Zimmermann-Laband syndrome 3
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Zimmermann-Laband syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 1-154772376-A-G is Benign according to our data. Variant chr1-154772376-A-G is described in ClinVar as [Benign]. Clinvar id is 403002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.41 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.96 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNN3NM_002249.6 linkc.1047T>C p.Asn349Asn synonymous_variant Exon 3 of 8 ENST00000271915.9 NP_002240.3 Q9UGI6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNN3ENST00000271915.9 linkc.1047T>C p.Asn349Asn synonymous_variant Exon 3 of 8 1 NM_002249.6 ENSP00000271915.3 Q9UGI6-1
KCNN3ENST00000361147.8 linkc.132T>C p.Asn44Asn synonymous_variant Exon 3 of 8 1 ENSP00000354764.4 Q9UGI6-2
KCNN3ENST00000358505.2 linkc.108T>C p.Asn36Asn synonymous_variant Exon 3 of 8 1 ENSP00000351295.2 Q9UGI6-3
KCNN3ENST00000618040.4 linkc.1047T>C p.Asn349Asn synonymous_variant Exon 3 of 9 5 ENSP00000481848.1 A0A087WYJ0

Frequencies

GnomAD3 genomes
AF:
0.717
AC:
109036
AN:
152082
Hom.:
39653
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.618
Gnomad AMI
AF:
0.558
Gnomad AMR
AF:
0.819
Gnomad ASJ
AF:
0.763
Gnomad EAS
AF:
0.982
Gnomad SAS
AF:
0.839
Gnomad FIN
AF:
0.692
Gnomad MID
AF:
0.823
Gnomad NFE
AF:
0.728
Gnomad OTH
AF:
0.738
GnomAD2 exomes
AF:
0.769
AC:
192467
AN:
250314
AF XY:
0.768
show subpopulations
Gnomad AFR exome
AF:
0.615
Gnomad AMR exome
AF:
0.877
Gnomad ASJ exome
AF:
0.756
Gnomad EAS exome
AF:
0.986
Gnomad FIN exome
AF:
0.693
Gnomad NFE exome
AF:
0.722
Gnomad OTH exome
AF:
0.754
GnomAD4 exome
AF:
0.740
AC:
1081752
AN:
1461434
Hom.:
403247
Cov.:
60
AF XY:
0.743
AC XY:
539901
AN XY:
727010
show subpopulations
African (AFR)
AF:
0.616
AC:
20627
AN:
33474
American (AMR)
AF:
0.869
AC:
38819
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.751
AC:
19629
AN:
26130
East Asian (EAS)
AF:
0.984
AC:
39050
AN:
39696
South Asian (SAS)
AF:
0.834
AC:
71912
AN:
86238
European-Finnish (FIN)
AF:
0.689
AC:
36782
AN:
53348
Middle Eastern (MID)
AF:
0.803
AC:
4628
AN:
5766
European-Non Finnish (NFE)
AF:
0.724
AC:
805142
AN:
1111708
Other (OTH)
AF:
0.748
AC:
45163
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
16195
32390
48584
64779
80974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20048
40096
60144
80192
100240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.717
AC:
109110
AN:
152200
Hom.:
39672
Cov.:
34
AF XY:
0.722
AC XY:
53715
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.618
AC:
25657
AN:
41526
American (AMR)
AF:
0.819
AC:
12538
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.763
AC:
2647
AN:
3470
East Asian (EAS)
AF:
0.982
AC:
5076
AN:
5168
South Asian (SAS)
AF:
0.839
AC:
4044
AN:
4822
European-Finnish (FIN)
AF:
0.692
AC:
7330
AN:
10594
Middle Eastern (MID)
AF:
0.816
AC:
240
AN:
294
European-Non Finnish (NFE)
AF:
0.728
AC:
49509
AN:
67990
Other (OTH)
AF:
0.738
AC:
1561
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1654
3308
4963
6617
8271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.731
Hom.:
85385
Bravo
AF:
0.723
Asia WGS
AF:
0.874
AC:
3035
AN:
3478
EpiCase
AF:
0.737
EpiControl
AF:
0.738

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Zimmermann-Laband syndrome 3 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
1.2
DANN
Benign
0.50
PhyloP100
-1.4
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1131820; hg19: chr1-154744852; COSMIC: COSV55222871; API